Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Irritable Bowel Syndrome, May 2025 Free Subscription Abstracts Retrieve all available abstracts of the following 91 articles: HTML format

Single Articles

1. BOS M, Monden R, Wray NR, Zhou Y, et al
   Familial coaggregation and shared familiality of functional and internalizing disorders in the Lifelines cohort.
   Psychol Med. 2025;55:e126.
   PubMed    
   Abstract available
   
   

2. BONTEMPO AC, Bontempo JM, Duberstein PR
   Ignored, dismissed, and minimized: Understanding the harmful consequences of invalidation in health care-A systematic meta-synthesis of qualitative research.
   Psychol Bull. 2025;151:399-427.
   PubMed    
   Abstract available
   
   

3. WHORWELL PJ
   Anticholinergic agents and impaired cognitive function: is there a risk for patients with irritable bowel syndrome?
   Therap Adv Gastroenterol. 2025;18:17562848251338479.
   PubMed    
   
   
   

4. DONG Z, Wang X, Xuan L, Wang J, et al
   The interaction effect between childhood trauma and negative events during adulthood on development and severity of irritable bowel syndrome.
   BMC Gastroenterol. 2025;25:321.
   PubMed    
   Abstract available
   
   

5. REMES-TROCHE JM, Coss-Adame E, Schmulson M, Garcia-Zermeno KR, et al
   Pharmacologic treatment of irritable bowel syndrome. Position statement of the Asociacion Mexicana de Gastroenterologia, 2024.
   Rev Gastroenterol Mex (Engl Ed). 2025 Apr 29:S2255-534X(25)00015.
   PubMed    
   Abstract available
   
   

6. FU Z, Liu CZ, Zheng Q, Chi LL, et al
   Efficacy of acupuncture at pain-sensitive acupoints for diarrhoea-predominant irritable bowel syndrome (IBS-D): protocol of a multicentre, randomised, sham-controlled trial.
   BMJ Open. 2025;15:e091082.
   PubMed    
   Abstract available
   
   

7. RICHTER V, Broide E, Shalem T, Cohen DL, et al
   Association Between Ethnicity and Treatment Preferences in Patients with Irritable Bowel Syndrome.
   Rambam Maimonides Med J. 2025;16.
   PubMed    
   Abstract available
   
   

8. AUDIBERT A, Mas-Orea X, Rey L, Belloy M, et al
   Toxoplasma gondii chronic infection decreases visceral nociception through peripheral opioid receptor signaling.
   PLoS Pathog. 2025;21:e1013106.
   PubMed    
   Abstract available
   
   

9. ALIYU AI, Katsumata R, Tornblom H, Simren M, et al
   Gastrointestinal transit abnormalities in irritable bowel syndrome and their relation to symptoms.
   Expert Rev Gastroenterol Hepatol. 2025.
   PubMed    
   Abstract available
   
   

10. SANZ MORALES P, Wijeyesekera A, Robertson MD, Major G, et al
    An in vitro batch culture study to assess the fermentation of human milk oligosaccharides by faecal microbiota from healthy and irritable bowel syndrome stool donors.
    Gut Microbiome (Camb). 2025;6:e4.
    PubMed    
    Abstract available
    
    

11. MUSTAFA F, Noor R, Murtaza A, Kanwal W, et al
    Small Intestinal Bacterial Overgrowth (SIBO) - Prevention and Therapeutic Role of Nutrition, Prebiotics, Probiotics, and Prokinetics.
    Curr Pharm Des. 2025 Apr 28. doi: 10.2174/0113816128373584250407134451.
    PubMed    
    Abstract available
    
    

12. ZHENG H, Chen Y, Lu S, Liu Z, et al
    Mechanosensory Piezo2 regulated by gut microbiota participates in the development of visceral hypersensitivity and intestinal dysmotility.
    Gut Microbes. 2025;17:2497399.
    PubMed    
    Abstract available
    
    

13. LI MG, Qu ST, Yu Y, Xu Z, et al
    Upregulation of NR2A in Glutamatergic VTA Neurons Contributes to Chronic Visceral Pain in Male Mice.
    Neurosci Bull. 2025 Apr 28. doi: 10.1007/s12264-025-01402.
    PubMed    
    Abstract available
    
    

14. MALLARDI D, Maqoud F, Guido D, Aloisio M, et al
    Mapping Research Trends on Intestinal Permeability in Irritable Bowel Syndrome with a Focus on Nutrition: A Bibliometric Analysis.
    Nutrients. 2025;17:1064.
    PubMed    
    Abstract available
    
    

15. SHOKRANI A, Seck A, Feng B, Pierce DM, et al
    Methods for Quantitative Analyses of Nerve Fiber Deformation in the Myenteric Plexus Under Loading of Mouse Distal Colon and Rectum.
    bioRxiv [Preprint]. 2025 Apr 8:2025.04.02.646858. doi: 10.1101/2025.04.02.646858
    PubMed    
    Abstract available
    
    

16. TANG Y, Tang X, Wen Q
    Analysis of Electroacupuncture Parameters for Irritable Bowel Syndrome: A Data Mining Approach.
    J Pain Res. 2025;18:2175-2189.
    PubMed    
    Abstract available
    
    

17. AGGELETOPOULOU I, Geramoutsos G, Pastras P, Triantos C, et al
    Vitamin D in Irritable Bowel Syndrome: Exploring Its Role in Symptom Relief and Pathophysiology.
    Nutrients. 2025;17:1028.
    PubMed    
    Abstract available
    
    

18. SAHU S, Varshney A, Chaudhary M, Ghoshal U, et al
    Irritable Bowel Syndrome-like Symptoms in Patients With Ulcerative Colitis in Remission as Compared to Irritable Bowel Syndrome: Symptom Severity and Inflammatory Markers.
    J Neurogastroenterol Motil. 2025 Apr 28. doi: 10.5056/jnm24010.
    PubMed    
    Abstract available
    
    

19. KENDLER KS, Ohlsson H, Neale M, van Loo H, et al
    A multivariate Swedish national twin-sibling study in women of major depression, anxiety disorder, fibromyalgia, and irritable bowel syndrome.
    Psychol Med. 2025;55:e125.
    PubMed    
    Abstract available
    
    

20. KROUCH D, Vreeke GJC, America AHP, Mes JJ, et al
    Amylase trypsin inhibitors activation of toll-like receptor 4 revisited: The dominance of lipopolysaccharides contamination.
    Int J Biol Macromol. 2025 Apr 25:143378. doi: 10.1016/j.ijbiomac.2025.143378.
    PubMed    
    Abstract available
    
    

21. HASLER R, Miks MH, Bajic D, Soyyilmaz B, et al
    Human milk oligosaccharides modulating inflammation in infants, adults and older individuals - from concepts to applications.
    Adv Nutr. 2025 Apr 24:100433. doi: 10.1016/j.advnut.2025.100433.
    PubMed    
    Abstract available
    
    

22. WOJAS O, Krzych-Falta E, Zybul P, Zalikowska-Gardocka M, et al
    The Overlap of Allergic Disorders and Upper Gastrointestinal Symptoms: Beyond Eosinophilic Esophagitis.
    Nutrients. 2025;17:1355.
    PubMed    
    Abstract available
    
    

23. BLACK CJ, Olano C, Quigley EMM, Ford AC, et al
    Common misconceptions and controversies in the management of irritable bowel syndrome.
    Nat Rev Gastroenterol Hepatol. 2025 Apr 25. doi: 10.1038/s41575-025-01065.
    PubMed    
    Abstract available
    
    

24. WU Y, Jiang Y, Gong Y, Yao T, et al
    A "Janus" structured nanoclay microgel system for targeted probiotic therapy in diarrhea-predominant irritable bowel syndrome.
    J Control Release. 2025;383:113769.
    PubMed    
    Abstract available
    
    

25. IZQUIERDO SANTERVAS S, Maroto Martin C, Fiz-Lopez A, Garrote Adrados JA, et al
    Small intestine bacterial overgrowth (SIBO) breath test does not predict symptom severity in gut-brain interaction disorders: role of anxiety, depression, and inflammatory biomarkers.
    Rev Esp Enferm Dig. 2025 Apr 25. doi: 10.17235/reed.2025.11157/2025.
    PubMed    
    Abstract available
    
    

26. LITVAK A, Geiger J, Ford B, Byrne MM, et al
    An 8-Year Experience of Robot-Assisted Laparoscopic Surgical Management of Median Arcuate Ligament Syndrome.
    Ann Vasc Surg. 2025;114:212-218.
    PubMed    
    Abstract available
    
    

27. SCARLATA K, Zickgraf HF, Satherley RM, Shapiro JM, et al
    A Call to Action: Unraveling the Nuance of Adapted Eating Behaviors in Individuals With Gastrointestinal Conditions.
    Clin Gastroenterol Hepatol. 2025;23:893-901.
    PubMed    
    Abstract available
    
    

28. LIU J, Liu L, Yang J, Zhao X, et al
    Gastrointestinal Symptoms and Psychological Conditions: A Literature Review with Emphasis on the Evidence in Military Personnel from China.
    Adv Ther. 2025 May 8. doi: 10.1007/s12325-025-03190.
    PubMed    
    Abstract available
    
    

29. SOLEIMANI E, Chitsaz M
    Structural modeling of IBS severity: the mediating role of negative meta-emotions in stress, hostile attribution, and cognitive bias - a cross-sectional study.
    Ann Med Surg (Lond). 2025;87:2633-2637.
    PubMed    
    Abstract available
    
    

30. BALLMER-WEBER B, Krieger-Grubel C
    [Food intolerances: more often suspected than confirmed].
    Praxis (Bern 1994). 2025;114:144-148.
    PubMed    
    Abstract available
    
    

31. PAWELEC-PECIAK O, Lanocha-Arendarczyk N, Grzeszczak K, Kosik-Bogacka D, et al
    The Role of Blastocystis spp. in the Etiology of Gastrointestinal and Autoimmune Diseases.
    Pathogens. 2025;14:313.
    PubMed    
    Abstract available
    
    

32. YAN B, Wang S, Chen J, Zhong X, et al
    Evaluation of cinitapride's efficacy and safety in treating functional dyspepsia with overlapping symptoms: a real-world study in Chinese healthcare settings.
    Rev Assoc Med Bras (1992). 2025;71:e20241628.
    PubMed    
    Abstract available
    
    

33. GUO Y, Wang L, Huang JQ, Lu MW, et al
    Valorization of Pomegranate Peel: Mechanisms and Clinical Applications in Irritable Bowel Syndrome Management.
    Int J Mol Sci. 2025;26:3530.
    PubMed    
    Abstract available
    
    

34. HONG G, Zhao Y, Zhou J, Hu L, et al
    Circadian rhythm perturbation causes IBS-like characteristics and altered fecal metabolome in mice.
    BMC Microbiol. 2025;25:274.
    PubMed    
    Abstract available
    
    

35. ZIPP CR, Semlitsch T, Togel G, Krenn C, et al
    An overview of systematic reviews on the efficacy and safety of osteopathic techniques.
    J Bodyw Mov Ther. 2025;42:1186-1197.
    PubMed    
    Abstract available
    
    

36. SOKMEN O, Dundar AN, Bagci U, Togay SO, et al
    The FODMAP-Reducing Potential of Sourdough-Derived Lactobacillus Strains From the Marmara Region of Turkey.
    Food Sci Nutr. 2025;13:e70241.
    PubMed    
    Abstract available
    
    

37. DENG Z, Wang K, Hou T
    Causality Between Irritable Bowel Syndrome and Suicide Attempt: A Mendelian Randomization Study.
    Brain Behav. 2025;15:e70513.
    PubMed    
    Abstract available
    
    

38. WANG C, Wang T, Chen Y, Lie W, et al
    Ebastine in combination with low-dose antidepressants for refractory irritable bowel syndrome: A randomized controlled trial.
    Technol Health Care. 2025 May 2:9287329251334289. doi: 10.1177/09287329251334289
    PubMed    
    Abstract available
    
    

39. HOD K, Marasco G, Colecchia L, Cremon C, et al
    Psychological and Clinical Factors Mediate Post-COVID-19 Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2025 May 15:e70079. doi: 10.1111/nmo.70079.
    PubMed    
    Abstract available
    
    

40. GOMEZ-ESCUDERO O, Remes-Troche JM, Coss-Adame E, Garcia-Zermeno KR, et al
    Clinical practice recommendations on the use of neuromodulators in gastroenterology: AMG (Asociacion Mexicana de Gastroenterologia) - AMNM (Asociacion Mexicana de Neurogastroenterologia y Motilidad) expert joint review.
    Rev Gastroenterol Mex (Engl Ed). 2025 May 14:S2255-534X(25)00007.
    PubMed    
    Abstract available
    
    

41. LEHNER MD, Ulsemer P, Christochowitz S
    Menthacarin, a proprietary combination of peppermint and caraway oil, alters cultured human fecal microbiota composition, resulting in increased SCFA production.
    Front Pharmacol. 2025;16:1569052.
    PubMed    
    Abstract available
    
    

42. TEMIDO MJ, Cristiano M, Gouveia C, Mesquita B, et al
    Antidepressants in irritable bowel syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Ann Gastroenterol. 2025;38:284-293.
    PubMed    
    Abstract available
    
    

43. JUBAERE A, Chowdhury FK, Newaz AAS, Islam S, et al
    Diagnostic Value of Fecal Lactoferrin in Differentiating Inflammatory Bowel Disease From Irritable Bowel Syndrome: A Comparative Study in a Bangladeshi Cohort.
    Cureus. 2025;17:e82187.
    PubMed    
    Abstract available
    
    

44. LI N, Ren J, Guan L, Xu Y, et al
    [Study on activation mechanism of SGCs in representation along the distribution of stomach meridian in IBS-D mice].
    Zhongguo Zhen Jiu. 2025;45:593-600.
    PubMed    
    Abstract available
    
    

45. MCGRATH IM, Rukins V, Laisk T, Mortlock S, et al
    Interaction between genetic risk and comorbid conditions in endometriosis.
    HGG Adv. 2025 May 13:100456. doi: 10.1016/j.xhgg.2025.100456.
    PubMed    
    Abstract available
    
    

46. DEVI D, Bhattacharya S, Tiwari S, Tripathi A, et al
    Exploring the Impact of Yoga Intervention on Psychological Symptoms in Irritable Bowel Syndrome Patients: A Randomized Controlled Study.
    Int J Yoga. 2025;18:58-66.
    PubMed    
    Abstract available
    
    

47. KASTI AN, Katsas K, Pavlidis DE, Stylianakis E, et al
    Clinical Trial: A Mediterranean Low-FODMAP Diet Alleviates Symptoms of Non-Constipation IBS-Randomized Controlled Study and Volatomics Analysis.
    Nutrients. 2025;17:1545.
    PubMed    
    Abstract available
    
    

48. VELASCO-ABURTO S, Llama-Palacios A, Sanchez MC, Ciudad MJ, et al
    Nutritional Approach to Small Intestinal Bacterial Overgrowth: A Narrative Review.
    Nutrients. 2025;17:1410.
    PubMed    
    Abstract available
    
    

49. LIN X, Xia L, Zhou Y, Xie J, et al
    Crosstalk Between Bile Acids and Intestinal Epithelium: Multidimensional Roles of Farnesoid X Receptor and Takeda G Protein Receptor 5.
    Int J Mol Sci. 2025;26:4240.
    PubMed    
    Abstract available
    
    

50. YU J, Wang Z, Chen Y, Dong Y, et al
    Restraint Stress Disrupted Intestinal Homeostasis via 5-HT/HTR7/Wnt/beta-Catenin/NF-kB Signaling.
    Int J Mol Sci. 2025;26:4021.
    PubMed    
    Abstract available
    
    

51. GILL SK, Kumari S, Biswal BK, Acharya BN, et al
    From pharmacophore predictions to pharmaceutical possibilities: an integrated approach to screen M(3) selective muscarinic receptor antagonist.
    Mol Divers. 2025 May 13. doi: 10.1007/s11030-025-11208.
    PubMed    
    Abstract available
    
    

52. XU J, Zhao X, Yang S, Tang M, et al
    Chlorogenic acid and intestinal health: mechanistic insights and therapeutic applications.
    Food Funct. 2025 May 13. doi: 10.1039/d5fo00853.
    PubMed    
    Abstract available
    
    

53. MOHAMED SIRAJ H, Usaid M, Shaikh S, Dalain M, et al
    Bacterial Histamine as a Therapeutic Target for Abdominal Pain in Irritable Bowel Syndrome: A Literature Review.
    Cureus. 2025;17:e82132.
    PubMed    
    Abstract available
    
    

54. HE T, Song LQ, Weng XY, Pan P, et al
    Clinical relevance of inflammatory markers in the evaluation of severity of ulcerative colitis: A retrospective study.
    Open Life Sci. 2025;20:20251088.
    PubMed    
    Abstract available
    
    

55. ZHANG Y, Lin Z, Yao Q, He J, et al
    Milk peptides alleviate irritable bowel syndrome by suppressing colonic mast cell activation and prostaglandin E2 production in mice.
    Food Res Int. 2025;211:116470.
    PubMed    
    Abstract available
    
    

56. KUMARI N, Pal Y, Tailor CS, Negi D, et al
    Unraveling the Nutritional Perspectives of Probiotics and Prebiotics in Female Healthcare.
    Recent Adv Food Nutr Agric. 2025.
    PubMed    
    Abstract available
    
    

57. AGHAMOHAMMADI V, Rezakhani Moghadam H, Najafi E, Nasiri K, et al
    Mindfulness is associated with the weight status, severity of disease, and severity of extra-intestinal symptoms among individuals with irritable bowel syndrome.
    Front Psychol. 2025;16:1545033.
    PubMed    
    Abstract available
    
    

58. ALRASHEEDI AA, Jahlan EA, Bakarman MA
    The effect of low-FODMAP diet on patients with irritable bowel syndrome.
    Sci Rep. 2025;15:16382.
    PubMed    
    Abstract available
    
    

59. MEMEL ZN, Shah ND, Beck KR
    Diet, nutraceuticals, and lifestyle interventions for the treatment and management of irritable bowel syndrome.
    Nutr Clin Pract. 2025 May 10. doi: 10.1002/ncp.11307.
    PubMed    
    Abstract available
    
    

60. HAGHIGHATDOOST F, Feizi A, Hajihashemi P, Ani A, et al
    The Association Between Ultra-Processed Foods Consumption and Disorders of Gut-Brain Interaction: The Isfahan Functional Disorders (ISFUN) Study.
    Neurogastroenterol Motil. 2025 May 7:e70071. doi: 10.1111/nmo.70071.
    PubMed    
    Abstract available
    
    

61. ROSSI CM, Lenti MV, Merli S, Fiorita M, et al
    Effect of seasonal exposure in aeroallergen-sensitised patients with irritable bowel syndrome-diarrhoea.
    Front Allergy. 2025;6:1568595.
    PubMed    
    Abstract available
    
    

62. CHOI NR, Choi WG, Park J, Kim YT, et al
    Scutellaria baicalensis extracts alleviate zymosan-induced irritable bowel syndrome symptoms by modulating inflammation and ion channel activity.
    Anim Cells Syst (Seoul). 2025;29:360-371.
    PubMed    
    Abstract available
    
    

63. NASAB SJ, Feizi A, Hajihashemi P, Entezari MH, et al
    Correction: Effects of Spirulina (Arthrospira) platensis supplementation on intestinal permeability, oxidative stress markers, quality of life, and disease severity in patients with constipation-predominant irritable bowel syndrome: a randomized doubl
    Nutr J. 2025;24:83.
    PubMed    
    
    
    

64. LI Q, Zhang J, Yang C, Dong X, et al
    Evaluation of post-market adverse events of lubiprostone: a real-world adverse event analysis from the FAERS database.
    BMC Gastroenterol. 2025;25:395.
    PubMed    
    Abstract available
    
    

65. AL SNIH GM, Bailey KR, Oblizajek NR, Bharucha AE, et al
    Symptoms of Constipation: Relationship between questionnaires and diaries and Impact on Quality of Life.
    Clin Gastroenterol Hepatol. 2025 May 20:S1542-3565(25)00426.
    PubMed    
    Abstract available
    
    

66. HASAN ABMN, Asaduzzaman M, Mahfuj MN, Islam R, et al
    Prevalence of irritable bowel syndrome and its association to mental health among the private university students of Dhaka, Bangladesh.
    PLOS Glob Public Health. 2025;5:e0004670.
    PubMed    
    Abstract available
    
    

67. MUGO CW, Church E, Horniblow RD, Mollan SP, et al
    Unravelling the gut-brain connection: a systematic review of migraine and the gut microbiome.
    J Headache Pain. 2025;26:125.
    PubMed    
    Abstract available
    
    

68. BHATTACHARYA R, Pratima K, Preeti, Ambedkar SN, et al
    Prevalence of psychiatric disorders in patients of irritable bowel syndrome fulfilling Rome IV criteria: An observational study.
    J Family Med Prim Care. 2025;14:1478-1485.
    PubMed    
    Abstract available
    
    

69. LIU H, Si S, Zhang H, Zhan S, et al
    Dissecting the bidirectional associations between the progression of gastrointestinal and endocrine diseases.
    Front Endocrinol (Lausanne). 2025;16:1538603.
    PubMed    
    Abstract available
    
    

70. HAJIANI S, Tajabadi Ebrahimi M, Sadeghi A, Zarrabi Ahrabi N, et al
    The impact of a multi-species probiotic supplementation on clinical symptoms and biochemical factors in patients with irritable bowel syndrome: a randomised controlled trial.
    Arch Physiol Biochem. 2025 May 20:1-11. doi: 10.1080/13813455.2025.2507749.
    PubMed    
    Abstract available
    
    

71. KRYNICKA P, Koulaouzidis G, Marlicz W, Koulaouzidis A, et al
    Innovations in the diagnosis, treatment, and management of disorders of gut-brain interaction (DGBI).
    Expert Rev Gastroenterol Hepatol. 2025.
    PubMed    
    Abstract available
    
    

72. RUSKA P, Jerkovic A, Sila S, Mocic Pavic A, et al
    Autonomic nervous system abnormalities in children with inflammatory bowel disease and irritable bowel syndrome: a comparative study.
    Clin Auton Res. 2025 May 19. doi: 10.1007/s10286-025-01134.
    PubMed    
    Abstract available
    
    

73. RAJA S, Teitelbaum JE, Pereira K, Guli K, et al
    Efficacy of low FODMAP diet in pediatric patients with disorders of gut-brain interaction.
    JPGN Rep. 2025;6:75-79.
    PubMed    
    Abstract available
    
    

74. ZHANG B
    Expression of transient receptor potential vanilloid type 1 (TRPV1) in colonic mucosa of patients with irritable bowel syndrome.
    Am J Transl Res. 2025;17:2782-2789.
    PubMed    
    Abstract available
    
    

75. MENDOZA-DOMINGUEZ G, Garrido-Santos ZM, Lau C, Balbuena R, et al
    Real-world experience with the diagnosis of bile acid malabsorption (BAM) using serum 7-alpha-C4 and 48-hour stool bile acids.
    Rev Gastroenterol Mex (Engl Ed). 2025 May 17:S2255-534X(25)00039.
    PubMed    
    Abstract available
    
    

76. CHENG HS, Tey YH, Hu SY, Yeo AYN, et al
    Advancements and Challenges in Modeling Mechanobiology in Intestinal Host-Microbiota Interaction.
    ACS Appl Mater Interfaces. 2025 May 18. doi: 10.1021/acsami.4c20961.
    PubMed    
    Abstract available
    
    

77. WILEMAN V, Chilcot J, Norton C, Hart A, et al
    Modifiable psychological factors are associated with clusters of pain, fatigue, faecal incontinence and IBS-type symptoms in inflammatory bowel disease: a latent profile analysis.
    J Crohns Colitis. 2024 Dec 5:jjae183. doi: 10.1093.
    PubMed    
    Abstract available
    
    

78. LI D, Yang J
    Methodological Challenges and Suggestions for Improvement in the Study of Irritable Bowel Syndrome Flora.
    Am J Gastroenterol. 2025 May 2. doi: 10.14309/ajg.0000000000003489.
    PubMed    
    
    
    

79. WEI J, Zhong Y, Li Y, Li J, et al
    Addressing Mechanistic and Subtype-specific Limitations in the Study on Fecal Proteolytic Bacteria and Staphylococcal Superantigens in Irritable Bowel Syndrome.
    Am J Gastroenterol. 2025 Apr 28. doi: 10.14309/ajg.0000000000003453.
    PubMed    
    
    
    

80. THERRIEN A, Akula S, Galeas-Pena M, Frank E, et al
    Hereditary Alpha-Tryptasemia is Associated with Ongoing Symptoms in Individuals with Celiac Disease Despite Following a Gluten-Free Diet.
    Am J Gastroenterol. 2025 May 14. doi: 10.14309/ajg.0000000000003537.
    PubMed    
    Abstract available
    
    

81. DUGGAL S, Mahapatra S, Garrison K, Robles A, et al
    Assessing Gastrointestinal Awareness on TikTok: A Content Analysis of Colorectal Cancer, IBS, and IBD Narratives.
    Am J Gastroenterol. 2025 May 14. doi: 10.14309/ajg.0000000000003539.
    PubMed    
    Abstract available
    
    

82. SAAB O, Al-Obaidi H, Algodi M, Algodi A, et al
    Yoga for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Am J Gastroenterol. 2025 May 13. doi: 10.14309/ajg.0000000000003524.
    PubMed    
    Abstract available
    
    

83. CALDART F, Gabriel C, Vauquelin B, Riviere P, et al
    Overlap of esophageal disorders of gut-brain interactions (E-DGBIs) and GERD is highly prevalent in patients with refractory reflux symptoms.
    Am J Gastroenterol. 2025 May 22. doi: 10.14309/ajg.0000000000003542.
    PubMed    
    Abstract available
    
    

84. SHARABI E, Busam JA, Mathur K, Rezaie A, et al
    Tracking Anti-cytolethal Distending Toxin B and Anti-vinculin Over Time and Their Roles in Symptoms.
    Dig Dis Sci. 2025 May 4. doi: 10.1007/s10620-025-09068.
    PubMed    
    Abstract available
    
    

85. MIHARA H, Kuraishi S, Fujinami H, Ando T, et al
    Investigation of Recognition Areas by Explainable AI for Colonoscopy Images of Irritable Bowel Syndrome.
    Digestion. 2025 Apr 29:1-11. doi: 10.1159/000546183.
    PubMed    
    Abstract available
    
    

86. ARIF TB, Ali SH, Bhojwani KD, Sadiq M, et al
    Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: a meta-analysis.
    Eur J Gastroenterol Hepatol. 2025 Apr 30. doi: 10.1097/MEG.0000000000002994.
    PubMed    
    Abstract available
    
    

87. QUIGLEY EMM
    Microbial Influences on Irritable Bowel Syndrome.
    Gastroenterol Clin North Am. 2025;54:351-365.
    PubMed    
    Abstract available
    
    

88. LAMICHHANE R, Gautam M, Fletcher JG, Bailey KR, et al
    Inadequate Propulsion and Pelvic Floor Relaxation in Dyssynergic Defecation: Insights from Synchronous Proctomanometry.
    Gastroenterology. 2025 Apr 30:S0016-5085(25)00651.
    PubMed    
    Abstract available
    
    

89. BHARADWAJ PK, Simon EG, Dave RG, Geevar T, et al
    Utility of rotational thrombo-elastometry as an objective measure of hypercoagulability in ulcerative colitis.
    Indian J Gastroenterol. 2025 Apr 26. doi: 10.1007/s12664-025-01759.
    PubMed    
    Abstract available
    
    

90. WANDER GS, Batta A
    Masked hypertension in irritable bowel syndrome: A cause for concern?
    Indian J Gastroenterol. 2025 May 7. doi: 10.1007/s12664-025-01791.
    PubMed    
    
    
    

91. POPE Q, Varma R, Tataru C, David MM, et al
    Learning a deep language model for microbiomes: The power of large scale unlabeled microbiome data.
    PLoS Comput Biol. 2025;21:e1011353.
    PubMed    
    Abstract available